BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9457699)

  • 21. Comparison of haemodialysis (HD) and post dilution haemofiltration (HF) on an unselected dialysis population.
    Baldamus CA; Schoeppe W; Koch KM
    Proc Eur Dial Transplant Assoc; 1978; 15():228-35. PubMed ID: 740667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracorporeal techniques in the treatment of poisoned patients.
    Pond SM
    Med J Aust; 1991 May; 154(9):617-22. PubMed ID: 2056948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program].
    Mydlík M; Dzúrik R; Derzsiová K; Spustová V
    Cas Lek Cesk; 1983 Dec; 122(51):1573-6. PubMed ID: 6652672
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning. A retrospective review of 42 patients.
    Hampson EC; Pond SM
    Med Toxicol Adverse Drug Exp; 1988; 3(1):64-71. PubMed ID: 3285127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemoperfusion in the management of end-stage renal disease.
    Winchester JF
    Life Support Syst; 1984; 2(2):107-11. PubMed ID: 6384670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearance rate and BP-ANN model in paraquat poisoned patients treated with hemoperfusion.
    Hu L; Hong G; Ma J; Wang X; Lin G; Zhang X; Lu Z
    Biomed Res Int; 2015; 2015():298253. PubMed ID: 25695058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemoperfusion treatment in pigs experimentally intoxicated by paraquat.
    Yang TS; Chang YL; Yen CK
    Hum Exp Toxicol; 1997 Dec; 16(12):709-15. PubMed ID: 9429084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
    De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemoperfusion: a useful therapy for a severely poisoned patient?
    De Broe ME; Bismuth C; De Groot G; Heath A; Okonek S; Ritz DR; Verpooten GA; Volans GN; Widdop B
    Hum Toxicol; 1986 Jan; 5(1):11-4. PubMed ID: 3949363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemodialysis with charcoal haemoperfusion.
    Winchester JF; Apiliga MT; Mackay JM; Kennedy AC
    Proc Eur Dial Transplant Assoc; 1976; 12():526-33. PubMed ID: 935131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modalities of hemodialysis: quality improvement.
    Karkar A
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1145-61. PubMed ID: 23168842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of paraquat.
    Bismuth C; Scherrmann JM; Garnier R; Baud FJ; Pontal PG
    Dev Toxicol Environ Sci; 1986; 12():347-56. PubMed ID: 3549236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
    Trznadel K; Walasek L; Kidawa Z; Lutz W
    Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evaluation of a composite sorbent for the treatment of paraquat intoxication by hemoperfusion.
    Lotan N; Siderman S; Tabak A; Taitelman U; Mihich H; Lupovich S
    Int J Artif Organs; 1983 Jul; 6(4):207-13. PubMed ID: 6629527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of haptoglobin phenotype in end-stage kidney disease.
    Burbea Z; Nakhoul F; Rosenberg S; Zoabi R; Skorecki K; Hochberg I; Miller-Lotan R; Benchetrit S; Weissgarten J; Knecht A; Tovbin D; Levy NS; Levy AP
    Nephron Exp Nephrol; 2004; 97(2):e71-6. PubMed ID: 15218325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the in vitro efficacy of hemodialysis, hemoperfusion, and the combined approach on the removal of metaldehyde from canine plasma.
    Mauser EL; Puschner B; Reese S; Hartmann K; Doerfelt R
    J Vet Emerg Crit Care (San Antonio); 2016 Jul; 26(4):516-23. PubMed ID: 27219514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorbent membrane dialysis in uremia.
    Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
    Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
    Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities of using hemoperfusion in the treatment of chronic kidney insufficiency].
    Falkenhagen D; Holtz M; Schmidt R; Osten B; Klinkmann H
    Z Urol Nephrol; 1979 Jan; 72(1):9-16. PubMed ID: 371244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.